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Dementia in military and veteran 
populations: a review of risk factors—traumatic 
brain injury, post-traumatic stress disorder, 
deployment, and sleep
Zara Raza1,2†, Syeda F. Hussain1,2†, Suzanne Ftouni3, Gershon Spitz4, Nick Caplin1,2, Russell G. Foster5 and 
Renata S. M. Gomes1,2,6*  
Abstract 
The military population face a unique set of risk factors that may increase the risk of being diagnosed with demen-
tia. Traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) have a higher prevalence in this group in 
comparison to the civilian population. By delving into the individual relationships between TBI and dementia, and 
PTSD and dementia, we are able to better explore dementia in the military and veteran populations. While there are 
some inconsistencies in results, the TBI-dementia association has become more widely accepted. Moderate-to-severe 
TBI has been found to increase the risk of being diagnosed with Alzheimer’s disease. A correlation between PTSD 
and dementia has been established, however, whether or not it is a causal relationship remains unclear. Factors such 
as blast, combat and chemical exposure may occur during a deployment, along with TBI and/or PTSD diagnosis, 
and can impact the risk of dementia. However, there is a lack of literature exploring the direct effects of deployment 
on dementia risk. Sleep problems have been observed to occur in those following TBI, PTSD and deployment. Poor 
sleep has been associated with possible dementia risk. Although limited studies have focused on the link between 
sleep and dementia in military and veteran populations, sleep is a valuable factor to study due to its association and 
interconnection with other military/veteran factors. This review aims to inform of various risk factors to the cognitive 
health of military members and veterans: TBI, PTSD, deployment, and sleep.
Keywords: Dementia, Alzheimer’s disease (AD), Traumatic brain injury (TBI), Post-traumatic stress disorder (PTSD), 
Military, Veteran, Deployment, Sleep
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Background
It was estimated that in 2020, there were 5.8 million peo-
ple aged 65  years and over living with the Alzheimer’s 
sub-type of dementia in the United States (U.S.) [1]. 
This estimated value is based on American census data 
from 2010 and a population study that looked at chronic 
health conditions within this age group [the Chicago 
Health and Aging Project (CHAP)]. With the number of 
people in this age group expected to almost double by 
2050, the number of dementia cases is also expected to 
drastically rise [2]. A survey done by the National Center 
for Veterans Analysis and Statistics in the U.S. found that 
the median age of male veterans was 65 [3]. A popula-
tion survey by the UK Ministry of Defence sub-grouped 
the veteran population in Great Britain according to age 
and found that those in the 60 and over age bracket com-
prised 70.5% of the 2.56 million veterans surveyed [4]. 
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This is the age range that is at greatest risk of developing 
dementia, and this risk is compounded by the fact that 
veterans face a unique set of risk factors such as trau-
matic brain injury (TBI) and post-traumatic stress disor-
der (PTSD).
The purpose of this review is to highlight research on 
dementia in military and veteran populations and to dis-
cuss the future implications of such knowledge. We aim 
to do so by exploring TBI, PTSD, military deployment, 
sleep and the respective relationships of these factors 
with dementia. We also aim to compare military/veteran 
and civilian studies, due to a lack of military-focused 
studies in some areas.
With dementia being an umbrella term used to encom-
pass several neurological conditions and symptoms, 
many studies use this term instead of specifying the types 
of dementia. Therefore, in this review, ‘dementia’ is used 
in instances where the literature has not specified the 
exact form of dementia. Alzheimer’s disease (AD) is the 
most common form of dementia and this is reflected in 
the reviewed literature, with frontotemporal demen-
tia (FTD), Parkinson’s disease dementia, dementia with 
Lewy bodies and vascular dementia also discussed.
Search strategy and selection criteria
This is a narrative review where search parameters were 
used. Searches of PubMed and Scopus were performed 
to obtain the data and articles for this review. The search 
terms used were ‘dementia’, ‘Alzheimer’s disease’, ‘trau-
matic brain injury’, ‘TBI’, ‘post-traumatic stress disorder’, 
‘PTSD’, ‘military’, ‘veteran’, ‘deployment’, ‘sleep’. Abstracts 
and articles were reviewed and included only if they met 
our criteria of discussing dementia (including AD), and 
if they were discussed within the context of TBI, PTSD, 
military deployment, and sleep. There was no date limita-
tion to the articles included.
Association between TBI and dementia
Military and veteran populations are known to comprise 
of individuals that experience TBI. Understanding the 
link between TBI and dementia is, therefore, valuable 
when exploring dementia in these groups. TBI has been 
considered a potential risk factor for dementia occur-
ring later in life. Numerous studies have established a link 
between moderate-to-severe TBI and the risk of devel-
oping AD—the most common cause of senile dementia 
in Europe and U.S. [5]. The key neuropathological signs 
of AD are amyloid β (Aβ)—containing plaques on the 
neurons of the brain, tangles of phosphorylated tau pro-
teins within neurons, synapse loss, and neuronal loss [6]. 
Presently, there are no treatments, nor early diagnostic 
biomarkers for AD [7]. Abnormal accumulation of pro-
teins in the brain is a commonly observed phenomenon 
in neurodegenerative diseases. In FTD, the characteristic 
protein is transactive response DNA-binding protein 43 
(TDP-43) [8], while α-synuclein is the hallmark protein 
for Parkinson’s disease [9]. Following a TBI, accumulation 
of Aβ, p-tau, α-synuclein, and TDP-43 tends to occur. 
Since the aforementioned neurodegenerative diseases 
and TBI share the same hallmark characteristic proteins, 
it has led to many investigations which explore the exact 
nature of the relationship between TBI and such diseases.
There are a number of factors that may potentially 
influence the risk of dementia after TBI [10, 11]. These 
include cognitive reserve, ApoE genotype and age at the 
time of injury. In addition to these, the risk of develop-
ing AD may depend on the severity of TBI. One prospec-
tive study on World War II Navy veterans found that 
individuals who suffered from severe TBI in early adult-
hood were four times more likely to develop AD, while 
those with moderate TBI were twice as likely compared 
to controls. However, there was no link found between 
mild TBI (mTBI) and a greater risk of AD [12]. The rela-
tionship between mTBI and dementia, however, has 
been explored in civilian settings. Lee et al. [13] used the 
National Health Insurance database to obtain informa-
tion for their cohort study. In contrast to the earlier study 
[12], this study concluded that mTBI is an independ-
ent risk factor in developing dementia. As previously 
mentioned, the risk of developing dementia can also be 
affected by the age at which the TBI occurs. In another 
cohort study with a follow-up period of 5–7 years, Gard-
ner et al. [14] reported that the risk of developing demen-
tia increased by 26% in those who were 55 years or older, 
in comparison to controls. Those who had sustained a 
single moderate-to-severe TBI were at increased risk of 
developing dementia regardless of age, while a mTBI was 
enough to raise the risk in those that were 65  years or 
older. This suggests that for patients who are older, a mild 
injury is enough to increase susceptibility to developing 
dementia, but in other age groups, only a moderate or 
severe injury may be potent enough to cause such effect.
A nationwide study using data from the Finnish Care 
Register for Health Care performed on the civilian work-
ing population (18–65  years) in Finland over a period 
of 30 years found that, those who suffered from moder-
ate-to-severe TBI (diagnosed between 1987 and 2014) 
were 90% more likely to develop dementia in compari-
son to those who had mTBI [15]. Another civilian study 
used data which contained financial health informa-
tion. Following adjustment for age, sex and year of index 
healthcare use, as well as comorbidities such as diabetes 
and stroke, the study found that there was a 1.68 times 
increased risk of developing dementia amongst those 
who had TBI [16].
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TBIs are often associated with a period of loss of con-
sciousness (LOC). Crane et al. [17] found that TBI with 
LOC (≤ 1 h) is associated with a greater risk of develop-
ing Lewy bodies in civilian populations, although they 
found no association with AD or dementia. Not all brain 
injuries are followed by a period of LOC yet, there has 
been speculation about whether or not TBIs without 
LOC can also raise the risk of dementia. Bazarian et  al. 
[18] found evidence that suggests an association between 
mTBI with LOC and AD, but insufficient evidence for 
mTBI without LOC. Barnes et  al. [19] studied this par-
ticular association in a large cohort study of 178,779 vet-
erans who were diagnosed with one or more TBIs in the 
Veterans Health Administration health care system. They 
found that the risk of dementia was just over two times 
greater for those with mTBI without LOC [hazard ratio 
(HR) 2.36, 95% CI 2.10–2.66] after adjusting for comor-
bidities, and even greater for mTBI with LOC (HR 2.51, 
95% CI 2.29–2.76). These results may reflect differences 
in mechanisms which differ according to injury sever-
ity. However, the reasoning behind the results’ varia-
tion of mTBI with and without LOC remains unclear, as 
there have been no further studies investigating this since 
then. Understanding the underlying mechanisms of how 
TBI with and without LOC may increase dementia risk 
requires further rigorous research.
Data from a study conducted by Johnson et  al.[20] 
showed that several years after a single moderate-to-
severe TBI, there was a greater density and distribution 
of tau and Aβ plaque pathology in comparison to age-
matched controls. This suggests that a single TBI may 
result in the development of long-term neurodegenera-
tive diseases of the AD type. The underlying pathogenesis 
of AD and the cause behind its increased risk of devel-
opment in relation to TBI remains unclear. AD is char-
acterised by the presence of extracellular senile plaques 
consisting of Aβ, and intracellular neurofibrillary tangles 
which are made of phosphorylated tau proteins [21]. Aβ 
deposition, tau phosphorylation, and microglial activa-
tion are some characteristics which are shared by acute 
TBIs and AD [22, 23]. One of the key effects of TBI is 
axonal damage or diffuse axonal injury (DAI) [24]. As 
a result of DAI, normal axonal transport is disturbed 
which can then lead to aberrant accumulation of amy-
loid precursor protein (APP) in the injured regions of the 
axon alongside cleavage facilitating β-site APP-cleaving 
enzyme (BACE1) and γ-secretase complex, which are 
responsible for cleaving APP into Aβ. This can result in 
abnormally rapid production and expression of Aβ which 
may, in turn, trigger the cascade of events leading to 
AD[25].
TBI and early onset dementia
With considerable evidence supporting an association 
between TBI and dementia, another interesting area 
to investigate is whether TBIs can induce earlier devel-
opment of dementia. One study looked at the risk of 
dementia in 188,764 older U.S. veterans (≥ 55  years). 
During a follow-up period of 9 years, it was found that of 
those who had TBI, 16% developed dementia, in compar-
ison to 10% of those without TBI. It was concluded that 
over the 9  year period the risk of developing dementia 
increased by 60%, and the age of onset of dementia less-
ened by 2  years in comparison to veterans without TBI 
[26]. A civilian study performed in 2016 which relied on 
the data obtained from the AD Neuroimaging Initiative 
determined that in those with a history of TBI, the age of 
dementia onset occurred at (68.2 ± 1.0) years, i.e. 2 years 
earlier than in those without a history of TBI (70.9 ± 0.2) 
years [27]. Early onset dementia or young onset dementia 
refer to dementia that occurs in those under the age of 
65 years. Nordström et al. [28] investigated whether the 
risk of young onset dementia increased as a consequence 
of TBI in a cohort of 811,622 Swedish men who had been 
conscripted for compulsory military service. The main 
outcome of this study was that for non-AD forms of 
dementia, there was a strong association of young onset 
dementia with TBIs of varying degrees of severity.
A less common type of dementia, FTD, has also been 
linked to TBI. A study of a U.S. veteran population (a 
sample of 554 patients) by Kalkonde et al. [29], utilising 
multivariate analysis, found that TBI is an independ-
ent risk factor for FTD; the prevalence of FTD was 4.4 
times greater in those with TBI compared to those with-
out. There are a number of possible hypotheses for the 
mechanism behind the development of FTD as a result of 
TBI. One is that the frontal and temporal lobes are more 
susceptible to injury due to their proximity to the rough 
interior surface of the base of the skull [30]. Another 
reason may be due to significantly lowered levels of pro-
granulin protein (PGRN). This can occur as a result of a 
TBI through the activation of the microglia in the brain 
and the subsequent adhesion of PGRN to other peptides 
facilitated by elastase, a protease released by microglia, 
thus lowering PGRN levels [31]. PGRN deficiency has 
been linked to FTD [32].
There are multiple studies which report a link between 
TBI and increased risk of dementia, however, it is impor-
tant to note that the relationship is not yet entirely con-
clusive as there have been studies that show conflicting 
results. The risk of dementia due to AD is generally asso-
ciated with moderate or severe TBIs, but the specific risk 
is still undetermined as most earlier studies relied purely 
on International Classification of Diseases (ICD) clinical 
diagnoses, and did not use any of the recently developed 
Page 4 of 13Raza et al. Military Med Res            (2021) 8:55 
biomarkers or neuropathological examinations for 
confirmation of aetiology [33, 34]. Complications can, 
therefore, arise due to the varying definitions for TBI, 
or misdiagnoses. Another limitation of epidemiologic 
studies for the TBI-AD relationship is that most of these 
studies used self-reported information to establish a his-
tory of TBI which, if obtained from those who already 
suffer from cognitive impairment, may not be reliable 
[33]. Other limitations include bias due to the use of 
case-controlled studies, reverse causation (undiagnosed 
AD resulting in TBI), misclassification and differing defi-
nitions of neurodegenerative diseases, and insufficient 
adjustment for covariates (age, sex, race, health, and life-
style variables e.g. drug or alcohol disorders, depression) 
[35].
Long term follow‑up studies
Presently, there are very few studies with a long follow-up 
period. This contributes to the lack of conclusiveness sur-
rounding the nature of the relationship between TBI and 
dementia since there is a greater possibility of misdiagno-
ses or reverse causality in studies with a short follow-up 
period. In a recent study, Nordström et  al. [36] investi-
gated this association using a large civilian population 
of 3,329,360 Swedish individuals over the age of 50 years 
over a long study period of up to 50  years. Overall, the 
results showed that the association between TBI and 
an increased risk of a dementia diagnosis was strongest 
in the first years following a TBI and, although the risk 
decreased over time, risk remained significantly higher 
more than 30 years later. It was also found that the risk 
of being diagnosed with dementia was greater for those 
that suffered from severe or multiple TBIs than in those 
who suffered from mild head trauma; a conclusion was 
also found in a previous study [15]. Another recent civil-
ian study [37], which utilises both a large population and 
a relatively long follow-up period, is based on data from 
2,794,852 Danish citizens who were all over the age of 
50  years. In agreement with the Nordström study [36], 
the risk of dementia was greatest immediately after the 
TBI. In the first 6 months following a TBI, the risk was 
about 4 times greater than the control group, and TBI 
remained a significant risk within the first 4  years after 
the injury. As seen in the Nordstrom study [36], there 
is a gradual decrease in the HR with time, although at 
more than 14 years there is still a risk of being diagnosed 
with dementia (HR 1.17, 95% CI 1.13–1.21). Even after 
adjusting for comorbidities, the risk of dementia was 24% 
greater in those with a history of TBI compared to those 
without.
The definition of TBI is uncertain when looking at 
many studies together, especially depending on the 
severity of the TBI and often, the lack of differentiation 
between severities. The possibility of individuals having 
experienced more than one TBI is not addressed in some 
studies and may have an impact on the risk of developing 
dementia. Other risk factors such as age, sex, and genetic 
status, are often not considered and these should all be 
taken into account when assessing the overall impact of 
TBI on dementia risk [11].
One study, focusing on self-reported TBI history in 
4761 American autopsy individuals, did not discover 
a significant association between AD neuropathologic 
changes and dementia [38]. The report recognises the 
contradiction of this finding with previous research. In 
comparison to other studies referenced above, which 
clinically diagnosed dementia based on ICD codes, 
this study performed neuropathological examinations. 
Authors suggest that previous studies which have found 
an association between TBI and dementia, may have mis-
classified or misdiagnosed dementia in their samples. 
This study did not assess the effects of single vs. multiple 
TBI, nor specify the severities of any of the TBI. Further-
more, a lack of significant association does not necessar-
ily mean that there is no effect. This, and other studies 
which rely on self-reporting, highlight an interesting 
point regarding effective and accurate TBI screening. 
It should be emphasised that the self-reported aspect 
of TBI, as mentioned before, is difficult to confirm and 
deduce conclusive information from. Self-reporting of 
TBI in this study [38] is based on a clinician-led inter-
view, but reporting of symptoms may differ according 
to how data is gathered and the type of symptoms being 
reported [39]. It may be more prudent to screen for TBI, 
especially remote screenings, using self-report question-
naires, clinician-led interviews, detailed physician inter-
views, and reviewing past hospital reports to ensure 
accuracy [39, 40].
In recent years, the association between TBI and 
dementia has become more widely accepted. While the 
more severe injuries have been accepted as a risk fac-
tor for dementia, it has been more difficult to establish 
whether mTBIs are a risk factor too. A recently con-
ducted meta-analysis consisting of twenty-one stud-
ies concluded that mTBIs can indeed contribute to an 
increased risk of dementia. After pooling together the 
results of twenty-one studies, authors calculated that 
individuals with a prior mTBI were 1.96 times more likely 
to develop dementia [41]. Characterising the effects of 
TBI is relevant and important outside of the sports and 
military spheres as these are not the only two populations 
that are subject to such injuries and their possible short- 
and long-term effects. With this in mind, the ability to 
diagnose and treat, or even prevent TBI, may be impor-
tant factors in reducing the risk and impact of dementia 
within all populations.
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Correlation between PTSD and dementia
PTSD is another disorder often linked to military and 
veteran populations, recognition of which is needed to 
better understand dementia prevalence in military and 
veteran populations. TBI and PTSD are distinctly differ-
ent disorders, however, they display some overlapping 
symptoms, e.g. attention or memory deficiencies, irrita-
bility, and sleep disturbances. Both disorders are preva-
lent in military and veteran populations and it may be 
difficult to distinguish between the two, especially as they 
can occur simultaneously [42]. Furthermore, research 
has shown an interesting association between PTSD 
and TBIs that have been acquired during deployment 
on brain volume. TBI causes reduction in volume of the 
bilateral hippocampus and right medial orbitofrontal 
cortex [43]. Researchers also found that if an individual 
has had a TBI, the injury itself may influence how PTSD 
affects the volume of the amygdala. Amygdala volume 
was seen to be lower in those with PTSD but not deploy-
ment TBI (however, this was not the case when corrected 
for multiple comparisons). This suggests that TBI may 
impact amygdala volume in the presence of PTSD [43].
Data collected from 2005 to 2015 shows that there 
was a total of 138,197 diagnoses of PTSD in individuals 
deployed during Operation Enduring Freedom, Opera-
tion Freedom’s Sentinel, Operation Iraqi Freedom, Oper-
ation New Dawn and Operation Inherent Resolve [44]. 
PTSD has been associated with a greater risk of demen-
tia incidence. Yaffe et al. [45] did a retrospective cohort 
study that focused on 181,093 veterans (≥ 55 years of age) 
enrolled at Department of Veterans Affairs (VA) health 
care services in the U.S. Taking into account other fac-
tors, for example, medical and neuropsychiatric disorders 
and demographics of the sample studied, 53,155 individ-
uals who were diagnosed with PTSD had nearly double 
the risk of developing dementia in comparison to those 
who did not have PTSD. The strongest link was found 
between PTSD and FTD.
Qureshi et al. [46] investigated the association between 
PTSD and dementia in older U.S. veterans. The database 
consisted of veterans (65 years or older) who had PTSD 
or received a Purple Heart (in this case awarded to mem-
bers who had only experienced psychological trauma). 
The veterans were matched and compared to members in 
a control group by age and sex. Accounting for cofound-
ing factors (e.g. number of clinic visits, TBI, alcohol abuse 
and dependence, coronary artery disease), this clinical 
investigation established that veterans with PTSD had 
double the incidence and prevalence of being diagnosed 
with dementia as those without PTSD. They also con-
cluded that it is unclear as to whether PTSD itself is a risk 
factor for dementia or whether the two have any com-
mon underlying risk factors, e.g. low baseline cognitive 
reserves. In a more recent study, however, Bhattarai 
et al. [47] identified PTSD as a significant risk factor for 
dementia in U.S. veterans, finding a moderate association 
between the two (OR 1.63, 95% CI 1.22–2.19).
Neuroanatomical effects
In terms of neuroanatomical effects, some studies have 
shown that PTSD results in a smaller hippocampal vol-
ume [48–50], though some show contradictory results 
[51, 52]. Smaller hippocampal volume has also been 
linked to AD, and the atrophy of the hippocampus is 
associated with the deposition of tau and TDP-43 [53]. 
Wang et  al. [54] suggested that there may be two pos-
sible pathways by which PTSD may induce dementia: 
1) a direct pathway that may occur through the over-
activation of the hypo-pituitary-adrenal (HPA) axis and 
the adrenergic system, which are part of the psychologi-
cal stress pathways, and 2) an indirect pathway whereby 
trauma induces changes to the anatomy of the brain, 
increasing the vulnerability and likelihood of developing 
dementia. Earlier-life trauma (multiple or single but long-
lasting) can act as a risk factor, resulting in the constant 
over-activation of the psychological stress pathway lead-
ing to later-life AD [55].
A more recent retrospective study [56] examined the 
risk of dementia in association with PTSD, and the role 
of antipsychotic use, in 15,612 male Vietnam veterans 
(55–65  years at baseline; 2001–2002). The results were 
not statistically significant, leading the authors to con-
clude that the risk of dementia does not increase in rela-
tion to PTSD. They did, however conclude that the use 
of antipsychotic drugs may contribute to an increased 
risk of dementia. The authors commented that the results 
should be interpreted with caution as the study is purely 
observational and rely on health diagnostic data, deter-
mination of disease severity and cognitive function meas-
ures [56]. An additional study of 417,172 U.S. veterans, 
conducted by Mawanda et al. [57], also explored the use 
of psychotropic drugs and dementia diagnosis in U.S. 
veterans. A stronger positive relationship between PTSD 
diagnosis and dementia diagnosis was reported in the 
group using psychotropic medication, in comparison to 
the group not using the medication. The patients which 
had been diagnosed with PTSD and were using selective 
serotonin reuptake inhibitors, novel antidepressants or 
atypical antipsychotics were at greater risk of being diag-
nosed with dementia in comparison to those with PTSD 
and not using these medications. Such findings suggest 
that the association between the number of psychotropic 
medication and dementia risk may be reflective of greater 
PTSD severity, as well as the presence of other psychiat-
ric comorbidities. Additional research is required to fur-
ther delineate this relationship.
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It is important to note that the onset of dementia can 
greatly exacerbate the effects of PTSD [58]. Research has 
also shown that on developing AD, those who have previ-
ously experienced PTSD may face reoccurrence or wors-
ening of those symptoms, suggesting a bidirectional link 
between dementia and PTSD [59]. A meta-analysis quan-
tified this association between PTSD and dementia, iden-
tifying PTSD as a risk factor, although the authors added 
that further research is required in order to determine 
whether there is a causal link or other contributing cofac-
tors [60]. A meta-analysis by Gunak et  al.showed that, 
amongst veterans, there is a HR of 1.61 (95% CI 1.46–
1.78) [60]. The link drawn between PTSD and dementia 
lacks conclusiveness, and the nature of the relationship is 
unclear. However, there is literature to support the notion 
of PTSD as a possible risk factor for dementia. Further 
research is required to better understand this relation-
ship and the impact of other cofactors such as PTSD 
medication on this relationship. Whether treatment for 
PTSD can increase or decrease the risk of dementia in 
an individual should be thoroughly investigated. Fur-
thermore, there needs to be a clear clinical confirmation 
for a PTSD diagnosis and/or TBI and any possible cau-
sality requires further research and confirmation. When 
considering dementia risk, prevention and severity in 
military and veteran populations, PTSD is an important 
factor to assess as it has the possibility to greatly impact a 
patient’s experience with dementia.
Military deployment and dementia
Military deployment is another informative factor to 
research when focusing on dementia in military and 
veteran populations. The difference between deployed 
and non-deployed individuals in the military is impor-
tant when trying to understand the specific neurological 
effects of combat on the brain. Deployment, in the con-
text of this literature review, can be defined as the period 
between when a military service member travels to a 
location for a combat mission and the individual’s return 
home after the mission [61]. The difference between 
this experience and that of non-deployed individu-
als is that non-deployed individuals are not involved in 
non-training physical combat actions. When examining 
health problems relating to veterans (for example PTSD, 
TBI, depression, anxiety), most studies do not take into 
account or specify whether veterans were deployed or 
non-deployed [62]. This needs to be taken into considera-
tion when assessing the significance of the study results.
Deployment and memory
Memory problems have been noted in deployed indi-
viduals. Chao [63] and Murphy et  al. [64] highlight the 
observation of memory problems in Gulf War veter-
ans returning from deployment. In view of such, Chao 
[63] investigated the impact of self-reported memory 
problems in deployed individuals on their performance 
in objective memory measures. The findings showed 
lower total learning, retention, and delayed recall scores 
in comparison to deployed veterans who did not have 
memory complaints. These results can be of use when 
assessing the impact of deployment on development of 
dementia, as subjective memory complaints have previ-
ously been linked to dementia incidence [65, 66].
Another study conducted by Chao [67] explored the 
outcome of chemical exposure during deployment on 
Gulf War veterans’ brain structure and function. There 
was an inverse association noted between exposure to 
chemicals that trigger a chemical alarm and visuospatial 
ability. A higher frequency of hearing chemical alarms 
was also related to a lower volume in specific areas of the 
brain (such as the lateral occipital cortex) responsible for 
visuospatial control. As problems in visuospatial function 
have been implicated in early stages of AD development 
[68] and with posterior cortical atrophy being a form of 
dementia presenting with visual symptoms [69], it would 
be useful to investigate deployed individuals who have 
been exposed to chemicals further in future research. 
A recently published brief report by Martinez et al. [70] 
shown that deployed U.S. veterans who were exposed 
to agent orange in the Vietnam era conflict were nearly 
twice as likely to receive a dementia diagnosis than those 
not exposed.
Acquired central auditory processing disorder 
(ACAPD) is a disorder associated with military deploy-
ment due to multiple possible factors such as blast 
exposure, TBI, hazardous noise exposure, and ototoxic 
solvents [71]. Signs of central auditory dysfunction have 
also been noted in patients with mild probable AD by 
Gates et al. [72]. It is, therefore, worth exploring the role 
of deployment on the development of dementia in rela-
tion to auditory dysfunction that military personnel may 
acquire when they are deployed. Another study carried 
out by Gates et  al. [73], 13  years later, found that those 
with impaired memory, with or without dementia, per-
formed worse on auditory processing tests. The research-
ers hypothesise that both memory and central auditory 
dysfunction occurring in the same individual may be due 
to a problem in the frontal lobe. They highlight that iso-
lated memory loss often precedes dementia diagnosis. 
These findings suggest that additional central auditory 
testing might be important in screening for early demen-
tia diagnosis.
Overall, there is a current lack of literature exploring 
the direct link between deployment and dementia devel-
opment, especially due to studies often not differentiating 
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between deployed and non-deployed participants. It is, 
therefore, valuable to consider the link between deploy-
ment and dementia through the lens of TBI and PTSD. 
Deployed soldiers expose themselves to life-threatening 
situations and the possibility of severe injury that can 
lead to disorders such as PTSD. Soldiers with greater 
exposure to combat are at greater risk of developing 
PTSD, in comparison to individuals who have a limited 
exposure [74]. A study performed on 715 twin veter-
ans who served in Southeast Asia presented a nine-fold 
increase in the occurrence of PTSD in the twin who expe-
rienced combat, in comparison to the other twin who 
was not deployed [75]. Shen et al. [76] studied the impact 
of differing deployment intensities on PTSD diagnosis. 
Authors found that those deployed to Iraq or Afghani-
stan had, respectively, a 6.3% and 1.6% higher probabil-
ity for positive PTSD screening than those who were not 
deployed. Another study by Shen et  al. [77] found the 
length of deployment to have an effect on PTSD risk; a 
deployment exceeding 180  days increased odds 1.11 
to 2.84 times, in comparison to a shorter deployment 
period. Meziab et al. [78] ran a retrospective study on a 
sample of U.S. prisoners of war, of which 31% had PTSD. 
The risk of dementia was increased in veterans who were 
prisoners of war only, or had PTSD only, but the risk of 
developing dementia was greatest for those who were 
prisoners of war and had PTSD. Contrarily, Jones et  al. 
[79] found that deployment itself did not play a role in the 
increase of PTSD risk. However, exposure to combat dur-
ing deployment increased the risk of PTSD development. 
It should be noted that PTSD deployment studies often 
do not take into account signs of PTSD preceding deploy-
ment [80] and, therefore, an observation of dementia as a 
result of PTSD in deployed individuals may not always be 
due to their experiences during deployment.
Deployment and TBI
TBI is another aspect to explore when examining the 
relationship between deployment and dementia. Regasa 
et  al. [81] conducted a retrospective study of 119,353 
active-duty U.S. military members and noted the risk of 
TBI diagnosis to increase 8.4-fold in the 4  weeks after 
returning from deployment, in comparison to before. 
During Operation Enduring Freedom and Operation 
Iraqi Freedom, 60% of wounded individuals exposed to 
combat were injured due to blasts from explosions [82]. 
A study of soldiers treated at Walter Reed Army Medical 
Centre conveyed that close to 60% who sustained inju-
ries from an explosion had a TBI [83]. The concern raised 
by combat exposure and the associated risk of TBI has 
also led to the implementation of the Post-Deployment 
Health Assessment from the Department of Defense 
and the Veterans Health Administration’s TBI screening 
questionnaire, which assesses all individuals returning 
from combat for TBI [84]. However, TBI may not always 
be a direct result of combat exposure; the Armed Forces 
Health Surveillance Centre presented data showing that 
falls/miscellaneous and land transport accidents were the 
main categories related to TBI-related diagnoses within 
a combined population in combat and noncombat set-
tings [85]. Furthermore, contrasting results in this area 
have been reported. The cognitive function observed 
in a group of 60 Operation Enduring Freedom/Opera-
tion Iraqi Freedom service members through neuropsy-
chological testing was similar in those exposed to blasts 
and those who were not [86]. This has also been noted in 
other studies [87, 88]. Therefore, blast exposure may not 
have as significant of an impact on the risk of developing 
dementia as other factors. However, given the small sam-
ple sizes in the studies, the lack of association between 
blast exposure and cognitive function may reflect low 
statistical power.
Assessing the impact of deployment itself on demen-
tia risk in military and veteran populations is difficult 
due to the multiple possible interacting factors. There is 
a large gap in the literature exploring the direct effects 
of deployment on dementia development, outside of any 
intermediary diagnosis, and this should be addressed. 
The studies discussed in this review, however, explore 
the individual experiences that military members may 
go through during deployment, such as injury to visual, 
auditory and neurological pathways, and their respec-
tive relationships to dementia, offering useful insight into 
the topic. There would be value in improving and adding 
to post-deployment health examinations that assess for 
memory, visuospatial and auditory function, as well as 
thorough investigation for TBI and PTSD, to possibly aid 
in prevention of dementia in later life.
Dementia and sleep
TBI, PTSD and military deployment are all factors that 
may be experienced by military and veteran populations. 
One aspect these factors all share is the possibility of 
sleep disturbance. Sleep, therefore, is a valuable part of 
an individual’s lifestyle to explore when considering the 
development of dementia in these groups.
Sleep issues in military and veteran populations
Military and veteran populations are known to suffer 
from sleep-related problems. Luxton et al. [89] explored 
short sleep duration (SSD) in redeployed Operation Iraqi 
Freedom service members. Seventy-two percent of 2738 
participants were found to sleep 6  h or less, qualifying 
them for experiencing SSD. Those exposed to combat 
were also more likely to have SSD than those who were 
not exposed. Sleep duration of less than 6  h was also 
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discussed to be the most noteworthy predictor for PTSD. 
The study aids in understanding the interconnected 
nature of deployment, PTSD and sleep, but further inves-
tigation into these topics may assist in understanding the 
link with dementia.
Peterson et al. [90] focused on deployed U.S. Air Force 
participants and found approximately 75% to report 
worse sleep quality after their deployment, in compari-
son to their sleep prior. This was a preliminary study that 
noted sleep efficiency and sleep onset latency of the par-
ticipants to be outside of the normal thresholds used to 
classify insomnia. A cross sectional study also reported 
that of those military personnel who returned from 
deployment with sleep disturbances, 88.2% were identi-
fied to suffer from a clinically significant sleep disorder, 
with 63.6% meeting the diagnostic criteria for insom-
nia [91]. Insomnia disorder was also noted in 57.2% of 
post-9/11 veterans in another study [92]. Hughes et  al. 
[93] discussed an integrated theoretical model to better 
understand insomnia in military and veteran populations. 
Authors discuss predisposing factors, precipitating fac-
tors and perpetuating factors, with military deployment 
and military retirement being examples of precipitating 
factors. These three types of factors convey the complex 
nature of insomnia and how major life events such as 
military service can initiate symptoms of insomnia in an 
individual, or exacerbate pre-existing symptoms. Insom-
nia symptoms are regarded as chronic, persisting many 
years after military service in some individuals, highlight-
ing the importance of addressing symptoms early on.
Sleep as a risk factor
The relationship between problems in sleep and demen-
tia has been explored in civilian populations. Lim et  al. 
[94] found that an increase in fragmented sleep led to 
an increased risk of developing AD. Individuals with the 
greatest noted sleep fragmentation were also 50% more 
likely to be at risk of developing AD than those with the 
lowest noted sleep fragmentation. This suggests a possi-
ble link between severity of sleep symptoms and higher 
likelihood of dementia risk. Shi et al. [95] did a system-
atic review and meta-analysis, noting that those who had 
sleep disturbances had 1.19 times the risk of developing 
all-cause dementia than those who did not have sleep 
disturbances. AD and vascular dementia risk were specif-
ically increased in those who suffered from sleep distur-
bances. Yaffe et al. [96] completed a retrospective cohort 
study using the data of 179,738 male veterans from the 
Department of VA. They found that male veterans above 
the age of 55 who experienced sleep disturbances had a 
27% increased risk of developing dementia, compared to 
those without. This study is a rare example of research 
discussing the link between sleep and dementia in the 
military and veteran populations and it focuses mostly on 
older male veterans. There is a lack of literature in this 
area and future research is recommended to consider 
the high number of military members and veterans who 
experience sleep difficulties.
Although the exact mechanisms underlying the link 
between dementia and sleep are not fully understood, 
sleep is known to play an important role in brain health 
restoration and a lack of sleep could impact brain cog-
nitive function. As the brain does not have a lymphatic 
system, the way in which it removes toxic waste has 
been referred to as the ‘glymphatic system’, which has 
been noted to have an enhanced function during sleep 
[97]. This may be important in AD pathogenesis as any 
problems in Aβ clearance may be linked to problems in 
sleep [98]. A rise in systemic inflammation has also been 
suggested as a possible mechanism for AD development 
through increased Aβ burden [99].
TBI and sleep
Despite few studies have directly explored the associa-
tion between sleep and dementia in military and veteran 
populations, there is research on TBI and PTSD, and 
their respective possible links with sleep. By delving into 
these relationships, we can try to better understand how 
much of an impact sleep may have on dementia risk in 
those with military or veteran backgrounds. One TBI 
cohort study found 46% of participants with TBI also had 
a sleep disorder, with obstructive sleep apnoea (OSA) 
noted in 23% of the group [100]. Insomnia is also known 
to be a common problem among those with TBI, with 
one study of 452 individuals with TBI reporting up to 
50% of people having insomnia symptoms [101]. Collen 
et al. [102] discussed similar results, with around half of 
116 participants with mild-to-moderate TBI presenting 
with insomnia symptoms. A total of 97.4% of participants 
in this study reported sleep problems, highlighting the 
importance of addressing sleep problems in TBI patients. 
The severity of sleep disturbances and the incidence of 
insomnia have also been found to increase with experi-
ence of multiple TBIs [103]. One contributing factor to 
consider is that, in those with TBI, melatonin produc-
tion is significantly lower than in controls [104, 105]. 
Melatonin is a hormone that is synthesised at night and 
is involved in regulating the sleep–wake cycle, thus, a 
reduction in melatonin production may alter sleep–wake 
cycles. Alongside the impact of the TBI itself, the result-
ing sleep difficulties following a TBI may additionally 
contribute to the development of dementia. Dementia is 
multifactorial and looking at the intermediate symptoms 
between TBI and dementia may help to establish the link 
better. The increase in dementia risk following a TBI may 
not, however, be due to sleep disorders themselves, but 
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the treatments associated with the sleep disorders. Chiu 
et al. [106] focused their research on the use of hypnot-
ics to treat insomnia in TBI patients. They found the risk 
of dementia to increase in those with TBI and insom-
nia taking hypnotics, in comparison to no increase in 
risk observed in TBI patients with insomnia who were 
not taking hypnotics. Once again, this may be reflective 
of greater TBI severity and associated comorbidities. 
The use of hypnotics increased the risk of developing 
dementia in the population-based study, but experienc-
ing insomnia alone did not. Thus, all factors that may 
contribute to dementia development are important to 
explore, including treatment of associated conditions.
PTSD and sleep
The incidence of sleep disturbances in individuals with 
PTSD is known to be high, with sleep disturbances pos-
sibly implicated in the early stages of PTSD, as well as the 
severity of PTSD [107]. One meta-analysis of 20 polysom-
nographic studies found greater stage 1 sleep and lower 
slow wave sleep in individuals with PTSD than those 
without [108]. Rapid eye movement (REM) density was 
also observed to be higher in the PTSD groups, suggest-
ing a possible change in REM function in these patients. 
Ohayon et al. [109] found that 39.6% of participants with 
PTSD met the Diagnostic and Statistical Manual (DSM) 
diagnostic standards for insomnia, in comparison to 6.5% 
of participants without PTSD. One review hypothesised 
the possibility of associations between sleep, PTSD and 
dementia through hippocampal damage [110]. Hip-
pocampal volume has been observed to be decreased 
in those with PTSD [111]. Interestingly, chronic sleep 
deprivation has also been associated with a reduction of 
hippocampal volume which may contribute to the devel-
opment of cognitive disorders and psychiatric diseases 
[112]. However, further research is needed to determine 
the extent and effect of hippocampal changes in associ-
ating sleep and dementia in PTSD patients. Neylan et al. 
[113] conducted a study on Vietnam veterans and found 
a higher percentage of veterans reporting difficulty fall-
ing asleep, difficulty maintaining sleep and experiencing 
nightmares in the group with PTSD than in the group 
without PTSD, or the civilian group. The possible sleep 
problems that may arise in patients following PTSD diag-
nosis could contribute to the overall dementia risk of 
the individual. It is useful to consider the involvement 
of sleep when looking at the link between PTSD and 
dementia.
By exploring the impact of sleep on the development 
of dementia in military and veteran populations, through 
the lens of TBI, PTSD and deployment, we are able to 
look more holistically at dementia patients who are part 
of these communities. Although there is research still to 
be done in order to understand the interaction of these 
factors better, the knowledge we already have about sleep 
could be implemented to help these patients. Problems in 
sleep have been implicated in the time following deploy-
ment, TBI and PTSD. Therefore, addressing sleep prob-
lems in deployed individuals or TBI and PTSD patients 
at an early stage would be valuable, and may play a part in 
understanding dementia risk, treatment, and prevention.
Other risk factors
It is recognised that other factors such as depression, 
diabetes, hypertension, and other traditional risk factors 
may also play an important part in the development of 
dementia in military populations. Yet, this paper focused 
on reviewing associations between the following risk fac-
tors: TBI, PTSD, deployment, and sleep.
Conclusion
Military deployment, TBI, PTSD and poor sleep might 
all contribute to dementia development in military and 
veteran populations, with differing measures of impact 
(Fig.  1). This is due to the complex nature of demen-
tia and the complexities of military and veteran experi-
ences. The link between TBI and dementia appears to be 
the strongest from the current literature reviewed, with 
moderate-to-severe TBI increasing the risk of demen-
tia development. PTSD, however, has also been associ-
ated with dementia risk, but further research to confirm 
the nature of this association is required. Deployment 
is usually noted to precede TBI and PTSD diagnosis in 
military and veteran populations, however, diagnoses can 
also occur independent of military deployment. Deploy-
ment itself may also affect memory directly, outside of 
TBI and PTSD diagnoses. Problems in sleep have been 
observed following military deployment, TBI and PTSD, 
however these can also occur independently, and can 
impact dementia development on their own. The exact 
order and nature of the interactions between TBI, PTSD, 
deployment and sleep are difficult to establish, however, 
it is possible that these factors may all simultaneously 
influence each other to increase risk of dementia devel-
opment. Further research exploring the direct effects of 
deployment on dementia is recommended, along with 
research specifically focusing on the link between sleep 
and dementia in military and veteran populations. By 
recognising TBI, PTSD, deployment and poor sleep as 
possible factors for dementia development in military 
and veteran populations, we can try to better understand 
the complex nature of dementia and aid in the preven-
tion, treatment and prognosis of dementia patients.
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